OTCMSSII
Market cap1.20bUSD
Dec 23, Last price
7.00USD
1D
40.00%
1Q
79.49%
IPO
-23.66%
Name
SS Innovations International Inc
Chart & Performance
P/E
—
P/S
203.42
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
127.96%
Rev. gr., 5y
%
Revenues
6m
+303.19%
Net income
-21m
L+273.86%
CFO
-14m
L+144.32%
Earnings
Mar 20, 2025
Profile
SS Innovations International, Inc. develops surgical robotic systems. It also develops SSI Mantra, a surgical robotic system; SSI Mudra, a range of surgical instruments that supports in surgical procedures, including robotic cardiac surgery; SSI Maya, a robotic surgery platform; and OMNI 3D HD provides live 3D HD view of the surgical field in robotic surgery operating room. The company is based in Fort Lauderdale, Florida.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | 5,880 303.19% | 1,458 | ||||||
Cost of revenue | 26,548 | 7,138 | 1,407 | |||||
Unusual Expense (Income) | ||||||||
NOPBT | (20,668) | (5,679) | (1,407) | |||||
NOPBT Margin | ||||||||
Operating Taxes | 3 | |||||||
Tax Rate | ||||||||
NOPAT | (20,668) | (5,679) | (1,407) | |||||
Net income | (20,942) 273.86% | (5,602) 277.38% | (1,484) 31.98% | |||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 808 | 1,500 | 518 | |||||
BB yield | -0.09% | |||||||
| Debt | ||||||||
Debt current | 6,308 | 10,244 | 145 | |||||
Long-term debt | 4,110 | |||||||
Deferred revenue | ||||||||
Other long-term liabilities | (1) | |||||||
Net debt | 744 | 8,676 | (261) | |||||
| Cash flow | ||||||||
Cash from operating activities | (13,573) | (5,555) | (363) | |||||
CAPEX | (2,763) | (220) | ||||||
Cash from investing activities | (2,299) | (2,736) | 38 | |||||
Cash from financing activities | 16,735 | 9,294 | 570 | |||||
FCF | (27,420) | (10,304) | (2,218) | |||||
| Balance | ||||||||
Cash | 7,033 | 1,568 | 406 | |||||
Long term investments | 2,640 | |||||||
Excess cash | 9,379 | 1,495 | 406 | |||||
Stockholders' equity | (34,741) | (13,466) | (8,016) | |||||
Invested Capital | 57,258 | 21,229 | 8,302 | |||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | 128,446 | 40,879 | 2,848 | |||||
Price | 7.25 | |||||||
Market cap | 931,230 | |||||||
EV | 931,975 | |||||||
EBITDA | (20,506) | (5,550) | (1,388) | |||||
EV/EBITDA | ||||||||
Interest | 523 | 162 | ||||||
Interest/NOPBT | ||||||||